Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Nevro Corp. Common Stock
(NY:
NVRO
)
5.840
UNCHANGED
Last Price
Updated: 7:00 PM EDT, Apr 2, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Nevro Corp. Common Stock
< Previous
1
2
3
4
5
Next >
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
↗
November 08, 2021
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...
Via
Benzinga
Looking into Nevro's Return on Capital Employed
↗
August 20, 2021
After pulling data from Benzinga Pro it seems like during Q2, Nevro's (NYSE:NVRO) reported sales totaled $102.33 million. Despite a 29.98% in earnings, the company posted a loss...
Via
Benzinga
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
↗
August 17, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc...
Via
Benzinga
What 12 Analyst Ratings Have To Say About Nevro
↗
August 05, 2021
Nevro (NYSE:NVRO) has observed the following analyst ratings within the last...
Via
Benzinga
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
↗
August 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
Earnings Scheduled For November 8, 2021
↗
November 08, 2021
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million. •...
Via
Benzinga
Preview: Nevro's Earnings
↗
November 05, 2021
Nevro (NYSE:NVRO) is set to give its latest quarterly earnings report on Monday, 2021-11-08. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
↗
August 16, 2021
On Monday morning, 207 companies hit new 52-week lows. Intriguing Points: The largest company in terms of market cap to set a new 52-week low was Koninklijke Philips (NYSE...
Via
Benzinga
Where Nevro Stands With Analysts
↗
July 09, 2021
Analysts have provided the following ratings for Nevro (NYSE:NV...
Via
Benzinga
A Look Into Nevro's Debt
↗
June 28, 2021
Over the past three months, shares of Nevro (NYSE:NVRO) increased by 18.38%. Before having a look at the importance of debt, let us look at how much debt Nevro has. Nevro...
Via
Benzinga
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
↗
August 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (...
Via
Benzinga
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
↗
August 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)...
Via
Benzinga
99 Biggest Movers From Yesterday
↗
August 06, 2021
Gainers Score Media and Gaming Inc. (NASDAQ: SCR) shares climbed 79.9% to close at $32.64 on Thursday after the company, and Penn National Gaming, announced they entered into a...
Via
Benzinga
Why Nevro Is Falling So Hard Today
↗
August 05, 2021
A narrower-than-expected loss was about the only bright spot in the company's second-quarter results.
Via
The Motley Fool
Mid-Afternoon Market Update: Nasdaq Rises 100 Points; SiTime Shares Gain After Strong Q2 Results
↗
August 05, 2021
Toward the end of trading Thursday, the Dow traded up 0.58% to 34,994.11 while the NASDAQ rose 0.69% to 14,881.97. The S&P also rose, gaining 0.42% to 4,421.35. The U.S. has...
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
August 05, 2021
Gainers Nautilus Biotechnology (NASDAQ:NAUT) stock rose 25.23% to $9.38 during Thursday's regular session. Nautilus Biotechnology's stock is trading at a volume of...
Via
Benzinga
Mid-Day Market Update: Dow Surges 200 Points; Itron Shares Tumble Following Downbeat Earnings
↗
August 05, 2021
Midway through trading Thursday, the Dow traded up 0.58% to 34,992.85 while the NASDAQ rose 0.61% to 14,870.44. The S&P also rose, gaining 0.14% to 4,420.81. The U.S. has the...
Via
Benzinga
Topics
Stocks
Nevro Stock Tanks After Q2 Earnings Miss, Analysts Move To Sidelines
↗
August 05, 2021
Nevro Corp (NYSE: NVRO) posted second-quarter revenue of $102.3 million, +81% Y/Y, missing the consensus of $107.7 million. Total U.S. permanent implant procedures...
Via
Benzinga
Topics
Earnings
Mid-Morning Market Update: Markets Open Higher; Kellogg Tops Q2 Views
↗
August 05, 2021
Following the market opening Thursday, the Dow traded up 0.49% to 34,961.76 while the NASDAQ rose 0.39% to 14,837.81. The S&P also rose, gaining 0.34% to 4,417.73. The U.S....
Via
Benzinga
Topics
Stocks
Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2021
↗
August 05, 2021
Upgrades Stephens & Co. upgraded the previous rating for Roku Inc (NASDAQ:
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
↗
August 05, 2021
During Thursday's morning session, 77 companies made new 52-week lows. Areas of Interest: The largest company in terms of market cap to set a new 52-week low...
Via
Benzinga
10 Biggest Price Target Changes For Thursday
↗
August 05, 2021
Keybanc boosted the price target for HubSpot, Inc. (NYSE:
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
August 05, 2021
Gainers Ensysce Biosciences (NASDAQ:ENSC) shares rose 42.78% to $5.84 during Thursday's pre-market session. The company's market cap stands at $141.7 million....
Via
Benzinga
Nevro Corp (NVRO) Q2 2021 Earnings Call Transcript
↗
August 05, 2021
NVRO earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
August 04, 2021
Gainers Scopus BioPharma (NASDAQ:SCPS) s...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 9, 2021
↗
July 09, 2021
h2>Upgrades According to HSBC, the prior rating for NIO Inc (NYSE:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2021
↗
July 06, 2021
Upgrades According to Citigroup, the prior rating for ORIC Pharmaceuticals Inc (NASDAQ:
Via
Benzinga
10 Biggest Price Target Changes For Tuesday
↗
July 06, 2021
Keybanc boosted NVIDIA Corporation (NASDAQ: NVDA) price target from $775 to $950. NVIDIA shares rose 0.6% to $824.60 in pre-market trading. Goldman Sachs boosted American...
Via
Benzinga
44 Stocks Moving In Monday's Mid-Day Session
↗
June 28, 2021
Gainers Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares climbed 43.5% to $127.44 after the company announced positive clinical data for its CRISPR therapy. Marin Software...
Via
Benzinga
60 Biggest Movers From Yesterday
↗
June 29, 2021
Gainers Marin Software Incorporated (NASDAQ: MRIN) surged 96.9% to close at $7.50. Marin Software, last week, announced it has added the ability to manage Instacart Ads to its...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today